Gefitinib is a tyrosine kinase inhibitor, indicated in advanced non-small cell lung cancer in all lines of treatment for patients harboring EGFR mutations. It has a favorable toxicity profile but may induce unexpected adverse effects, such as an infiammatory reaction in the bladder. We report a rare case of hemorrhagic cystitis, an unusual side effect, in a patient with non-small cell lung cancer treated with gefitinib, which did not compromise the clinical response.
GridelliC., De MarinisF., Di MaioM., CortinovisD., CappuzzoF., MokT.: Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation. Review of the evidence.Lung Cancer, 71: 249–257, 2011.
2.
LeeJ.S.: Randomized phase III study of gefitinib (Iressa™) versus standard chemotherapy (gemcitabine plus cisplatin) as a first-line treatment for never-smokers with advanced or metastatic adenocarcinoma of the lung. Presented at the 13th World Conference on Lung Cancer, July 31-August 4, San Francisco, 2009.
3.
CostanzoR., PiccirilloM.C., SandomenicoC., CarillioG., MontaninoA., DanieleG., GiordanoP., BryceJ., De FeoG., Di MaioM., RoccoG., NormannoN., PerroneF., MorabitoA.: Gefitinib in non small cell lung cancer.J Biomed Biotechnol, article ID 815269, 2011.
NakagawaM., NishimuraT., TeramukaiS., TadaH., TanakaF., YanagiharaK., FuruseK., WadaH., FukushimaM.: Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer-a retrospective analysis: JMTO LC03-02.BMC Res Notes, 2: 157, 2009.
6.
van ZandwijkN.: Tolerability of gefitinib in patients receiving treatment in everyday clinical practice.Br J Cancer, 89: S9–S14, 2003.
7.
NihoS., KubotaK., GotoK., YohK., OhmatsuH., KakinumaR., SaijoN., NishiwakiY.: First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study.J Clin Oncol, 24: 64–69, 2006.
ArakawaM., NakamuraK., YamadaY., RosserC.J., TobiumeM., SaitoH., HasegawaT., HondaN.: Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report.BMC Urol, 10: 6, 2010.
10.
SongH., ChenL.: Unusual side effect and dramatic response from gefitinib as first-line use in a male patient with bronchioloalveolar carcinoma.Chinese-German Journal of Clinical Oncology, 6: 601–602, 2007.
11.
MoriH., OhnoY., ItoF., FunaguchiN., YanaseK., EndoJ., NakanoM., Bai LaB.L., MinatoguchiS.: Massive hematuria from the bilateral upper urinary tract in a patient treated for advanced lung cancer with gefitinib.Jpn J Clin Oncol, 40: 263–266, 2010.
12.
eHealthMe:Could Iressa cause cystitis haemorrhagic?
